MarketBeat Instant News Alerts 2 hours agoCanaccord Genuity Group Forecasts Strong Price Appreciation for Evolent Health (NYSE:EVH) StockMarketBeatCanaccord Genuity Group raised their price objective on Evolent Health from $6.00 to $7.00 and gave the company a "buy" rating in a report on Tuesday.NYSE:EVHRead Canaccord Genuity Group Forecasts Strong Price Appreciation for Evolent Health (NYSE:EVH) Stock2 hours agoCanaccord Genuity Group Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) StockMarketBeatCanaccord Genuity Group upped their target price on shares of Hinge Health from $76.00 to $100.00 and gave the stock a "buy" rating in a research report on Tuesday.NYSE:HNGERead Canaccord Genuity Group Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock2 hours agoNeedham & Company LLC Reiterates Buy Rating for Park Aerospace (NYSE:PKE)MarketBeatNeedham & Company LLC restated a "buy" rating and set a $43.00 price target on shares of Park Aerospace in a report on Tuesday.NYSE:PKERead Needham & Company LLC Reiterates Buy Rating for Park Aerospace (NYSE:PKE)2 hours agoS&P Global (NYSE:SPGI) Price Target Raised to $521.00MarketBeatRobert W. Baird boosted their target price on shares of S&P Global from $520.00 to $521.00 and gave the stock an "outperform" rating in a research report on Tuesday.NYSE:SPGIRead S&P Global (NYSE:SPGI) Price Target Raised to $521.002 hours agoTeladoc Health (NYSE:TDOC) Price Target Raised to $11.00 at Canaccord Genuity GroupMarketBeatCanaccord Genuity Group boosted their price objective on Teladoc Health from $10.00 to $11.00 and gave the stock a "buy" rating in a research note on Tuesday.NYSE:TDOCRead Teladoc Health (NYSE:TDOC) Price Target Raised to $11.00 at Canaccord Genuity Group2 hours agoStifel Nicolaus Boosts ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $25.00MarketBeatStifel Nicolaus increased their price target on shares of ACADIA Pharmaceuticals from $24.00 to $25.00 and gave the company a "hold" rating in a research report on Tuesday.NASDAQ:ACADRead Stifel Nicolaus Boosts ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $25.00 Trending News1BlackBerry (NYSE:BB) Stock Price Down 8.9% - Should You Sell?2Barclays Issues Pessimistic Forecast for TELUS (TSE:T) Stock Price3IonQ (NYSE:IONQ) Stock Price Down 6.6% - Here's Why4USA Rare Earth (NASDAQ:USAR) Shares Down 8.1% - Here's What Happened5SpaceX (NASDAQ:SPCX) Stock Price Down 3.1% - Here's Why6Erste Group Bank Analysts Raise Earnings Estimates for MRVL7SoFi Technologies (NASDAQ:SOFI) Shares Down 3.1% - Here's What Happened8CoreWeave (NASDAQ:CRWV) Shares Down 5.5% on Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoCanaccord Genuity Group Forecasts Strong Price Appreciation for Clover Health Investments (NASDAQ:CLOV) StockMarketBeatNASDAQ:CLOVRead Canaccord Genuity Group Forecasts Strong Price Appreciation for Clover Health Investments (NASDAQ:CLOV) Stock2 hours agoHC Wainwright Reiterates Buy Rating for Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA)MarketBeatNASDAQ:DMRARead HC Wainwright Reiterates Buy Rating for Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA)2 hours agoDomino's Pizza (NASDAQ:DPZ) Given New $415.00 Price Target at OppenheimerMarketBeatNASDAQ:DPZRead Domino's Pizza (NASDAQ:DPZ) Given New $415.00 Price Target at Oppenheimer2 hours agoDomino's Pizza (NASDAQ:DPZ) Earns "Buy" Rating from BTIG ResearchMarketBeatNASDAQ:DPZRead Domino's Pizza (NASDAQ:DPZ) Earns "Buy" Rating from BTIG Research2 hours agoFlywire (NASDAQ:FLYW) Given "Buy" Rating at BTIG ResearchMarketBeatNASDAQ:FLYWRead Flywire (NASDAQ:FLYW) Given "Buy" Rating at BTIG Research2 hours agoHalozyme Therapeutics (NASDAQ:HALO) Given Buy Rating at HC WainwrightMarketBeatNASDAQ:HALORead Halozyme Therapeutics (NASDAQ:HALO) Given Buy Rating at HC Wainwright2 hours agoCanaccord Genuity Group Increases Health Catalyst (NASDAQ:HCAT) Price Target to $3.00MarketBeatNASDAQ:HCATRead Canaccord Genuity Group Increases Health Catalyst (NASDAQ:HCAT) Price Target to $3.002 hours agoNeedham & Company LLC Issues Positive Forecast for Robinhood Markets (NASDAQ:HOOD) Stock PriceMarketBeatNASDAQ:HOODRead Needham & Company LLC Issues Positive Forecast for Robinhood Markets (NASDAQ:HOOD) Stock Price2 hours agoHarrow (NASDAQ:HROW) Receives Buy Rating from BTIG ResearchMarketBeatNASDAQ:HROWRead Harrow (NASDAQ:HROW) Receives Buy Rating from BTIG Research2 hours agoHealthStream (NASDAQ:HSTM) Price Target Raised to $27.00 at Canaccord Genuity GroupMarketBeatNASDAQ:HSTMRead HealthStream (NASDAQ:HSTM) Price Target Raised to $27.00 at Canaccord Genuity Group2 hours agoRosenblatt Securities Reiterates "Buy" Rating for Hut 8 (NASDAQ:HUT)MarketBeatNASDAQ:HUTRead Rosenblatt Securities Reiterates "Buy" Rating for Hut 8 (NASDAQ:HUT)2 hours agoIncyte (NASDAQ:INCY) Earns "Buy" Rating from HC WainwrightMarketBeatNASDAQ:INCYRead Incyte (NASDAQ:INCY) Earns "Buy" Rating from HC Wainwright2 hours agoIREN (NASDAQ:IREN) Given "Buy" Rating at Canaccord Genuity GroupMarketBeatNASDAQ:IRENRead IREN (NASDAQ:IREN) Given "Buy" Rating at Canaccord Genuity Group2 hours agoKestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at OppenheimerMarketBeatNASDAQ:KMTSRead Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Oppenheimer2 hours agoCanaccord Genuity Group Forecasts Strong Price Appreciation for LifeStance Health Group (NASDAQ:LFST) StockMarketBeatNASDAQ:LFSTRead Canaccord Genuity Group Forecasts Strong Price Appreciation for LifeStance Health Group (NASDAQ:LFST) Stock2 hours agoRothschild & Co Redburn Forecasts Strong Price Appreciation for Meta Platforms (NASDAQ:META) StockMarketBeatNASDAQ:METARead Rothschild & Co Redburn Forecasts Strong Price Appreciation for Meta Platforms (NASDAQ:META) Stock2 hours agoOmada Health (NASDAQ:OMDA) Price Target Raised to $28.00 at Canaccord Genuity GroupMarketBeatNASDAQ:OMDARead Omada Health (NASDAQ:OMDA) Price Target Raised to $28.00 at Canaccord Genuity Group2 hours agoCanaccord Genuity Group Forecasts Strong Price Appreciation for Progyny (NASDAQ:PGNY) StockMarketBeatNASDAQ:PGNYRead Canaccord Genuity Group Forecasts Strong Price Appreciation for Progyny (NASDAQ:PGNY) Stock2 hours agoZions Bancorporation, N.A. (NASDAQ:ZION) Stock Price Expected to Rise, Robert W. Baird Analyst SaysMarketBeatNASDAQ:ZIONRead Zions Bancorporation, N.A. (NASDAQ:ZION) Stock Price Expected to Rise, Robert W. Baird Analyst Says2 hours agoMitie Group AGM: Q1 Revenue Jumps 10% as Board Backs £3.1B OCS TakeoverMarketBeatLON:MTORead Mitie Group AGM: Q1 Revenue Jumps 10% as Board Backs £3.1B OCS Takeover2 hours agoCompass Group Q3 Earnings Call HighlightsMarketBeatLON:CPGRead Compass Group Q3 Earnings Call Highlights2 hours agoGenuine Parts (NYSE:GPC) Announces Earnings ResultsMarketBeatNYSE:GPCRead Genuine Parts (NYSE:GPC) Announces Earnings Results2 hours agoNorthrop Grumman (NYSE:NOC) Announces Quarterly Earnings ResultsMarketBeatNYSE:NOCRead Northrop Grumman (NYSE:NOC) Announces Quarterly Earnings Results2 hours agoAlly Financial (NYSE:ALLY) Issues Earnings Results, Misses Expectations By $0.03 EPSMarketBeatNYSE:ALLYRead Ally Financial (NYSE:ALLY) Issues Earnings Results, Misses Expectations By $0.03 EPS Featured Articles and OffersWhy Abbott Laboratories Stock Is Suddenly Winning Back Wall StreetBy Thomas Hughes | July 16, 2026A letter from Shannon StansberryFrom Porter & Company (Ad)The Ugliest Stocks in the Market Just Got a Very Expensive Vote of ConfidenceBy Bridget Bennett | July 20, 2026Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity YetBy Thomas Hughes | July 14, 2026Why Johnson & Johnson’s Earnings Dip Looks Like a Buying OpportunityBy Thomas Hughes | July 15, 2026Three companies about to leapfrog Nvidia [And transform the entire industry]From Eagle Publishing (Ad)Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to BenefitBy Dan Schmidt | July 19, 20262 Quantum Stocks That Could Challenge IonQ’s LeadershipBy Nathan Reiff | July 15, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 444 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
